Impaired Glucose Metabolisms of Patients with Obstructive Sleep Apnea and Type 2 Diabetes

Table 3

Baseline characteristics of T2DM.

Parameters	Mild-to-moderate OSA ()	Severe OSA ()
Duration of T2DM (months)	36.00 (24.00, 60.00)	36.00 (18.00, 114.00)	0.497
Therapies
Diet and exercise	1 (14.29)	2 (15.38)	0.730
Oral antidiabetic agents	2 (28.57)	4 (30.77)	0.664
Insulin	3 (42.85)	5 (38.47)	0.608
Oral antidiabetic agents and insulin	1 (14.29)	2 (15.38)	0.730
Chronic complications
Macrovascular complication	2 (28.57)	5 (38.47)	0.526
Nephropathy	3 (42.85)	1 (7.69)	0.101
Retinopathy	2 (28.57)	0 (0)	0.111
Neuropathy	1 (14.29)	3 (23.08)	0.561

Continuous data with nonnormal distribution are presented as median (first quartile, third quartile), and noncontinuous data are presented as number (%).